A pas de deux of osteoporosis and sarcopenia: osteosarcopenia
Open Access
- 26 July 2021
- journal article
- other
- Published by Taylor & Francis in Climacteric
- Vol. 25 (1) , 88-95
Abstract
The musculoskeletal conditions osteoporosis and sarcopenia are highly prevalent in older adults. Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone, whereas sarcopenia is identified by the loss of muscle strength, function and mass. Osteoporosis represents a major health problem contributing to millions of fractures worldwide on an annual basis, whereas sarcopenia is associated with a range of adverse physical and metabolic outcomes. They both affect physical and social function, confidence and quality of life as well as contributing to high health-care costs worldwide. Osteosarcopenia is the term given when both conditions occur concomitantly and it has been suggested that interactions between these two conditions may accelerate individual disease progression as co-existence of osteoporosis and sarcopenia is associated with higher morbidity from falls, fracture, disability as well as mortality. In this review, we will outline the epidemiology, pathogenesis and clinical consequences of osteosarcopenia and discuss available management strategies.Keywords
This publication has 115 references indexed in Scilit:
- Gender specific age-related changes in bone density, muscle strength and functional performance in the elderly: a-10 year prospective population-based studyBMC Geriatrics, 2013
- Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunityJournal of Bone and Mineral Research, 2011
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trialJournal of Cachexia, Sarcopenia and Muscle, 2011
- Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fractureArchives of Gerontology and Geriatrics, 2011
- Can an NSAID a day keep muscle wasting away?The Journal of Physiology, 2009
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- The COX-2 pathway is essential during early stages of skeletal muscle regenerationAmerican Journal of Physiology-Cell Physiology, 2004
- Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapyClinical Science, 1999
- GENETICS OF OSTEOPOROSISRheumatology, 1994